151 related articles for article (PubMed ID: 26788508)
21. The role of human epidermal growth factor receptor 2 as a prognostic factor in lung cancer: a meta-analysis of published data.
Liu L; Shao X; Gao W; Bai J; Wang R; Huang P; Yin Y; Liu P; Shu Y
J Thorac Oncol; 2010 Dec; 5(12):1922-32. PubMed ID: 21155183
[TBL] [Abstract][Full Text] [Related]
22. Frequency of fibroblast growth factor receptor 1 gene amplification in oral tongue squamous cell carcinomas and associations with clinical features and patient outcome.
Young RJ; Lim AM; Angel C; Collins M; Deb S; Corry J; Wiesenfeld D; Kleid S; Sigston E; Lyons B; Russell PA; Wright G; McArthur GA; Fox SB; Rischin D; Solomon B
Oral Oncol; 2013 Jun; 49(6):576-81. PubMed ID: 23434054
[TBL] [Abstract][Full Text] [Related]
23. FGF2/FGFR1 regulates autophagy in FGFR1-amplified non-small cell lung cancer cells.
Yuan H; Li ZM; Shao J; Ji WX; Xia W; Lu S
J Exp Clin Cancer Res; 2017 May; 36(1):72. PubMed ID: 28558758
[TBL] [Abstract][Full Text] [Related]
24. FGFR1 amplification in squamous cell carcinoma of the lung.
Heist RS; Mino-Kenudson M; Sequist LV; Tammireddy S; Morrissey L; Christiani DC; Engelman JA; Iafrate AJ
J Thorac Oncol; 2012 Dec; 7(12):1775-1780. PubMed ID: 23154548
[TBL] [Abstract][Full Text] [Related]
25. Fibroblast growth factor receptor 1 gene amplification and protein expression in human lung cancer.
Elakad O; Lois AM; Schmitz K; Yao S; Hugo S; Lukat L; Hinterthaner M; Danner BC; von Hammerstein-Equord A; Reuter-Jessen K; Schildhaus HU; Ströbel P; Bohnenberger H
Cancer Med; 2020 May; 9(10):3574-3583. PubMed ID: 32207251
[TBL] [Abstract][Full Text] [Related]
26. Low prognostic implication of fibroblast growth factor family activation in triple-negative breast cancer subsets.
Lee HJ; Seo AN; Park SY; Kim JY; Park JY; Yu JH; Ahn JH; Gong G
Ann Surg Oncol; 2014 May; 21(5):1561-8. PubMed ID: 24385208
[TBL] [Abstract][Full Text] [Related]
27. Impact of fibroblast growth factor receptor 1 (FGFR1) amplification on the prognosis of breast cancer patients.
Erber R; Rübner M; Davenport S; Hauke S; Beckmann MW; Hartmann A; Häberle L; Gass P; Press MF; Fasching PA
Breast Cancer Res Treat; 2020 Nov; 184(2):311-324. PubMed ID: 32852708
[TBL] [Abstract][Full Text] [Related]
28. High rate of FGFR1 amplifications in brain metastases of squamous and non-squamous lung cancer.
Preusser M; Berghoff AS; Berger W; Ilhan-Mutlu A; Dinhof C; Widhalm G; Dieckmann K; Wöhrer A; Hackl M; von Deimling A; Streubel B; Birner P
Lung Cancer; 2014 Jan; 83(1):83-9. PubMed ID: 24183471
[TBL] [Abstract][Full Text] [Related]
29. Fibroblast growth factor receptor 1 gene amplification in pancreatic ductal adenocarcinoma.
Lehnen NC; von Mässenhausen A; Kalthoff H; Zhou H; Glowka T; Schütte U; Höller T; Riesner K; Boehm D; Merkelbach-Bruse S; Kirfel J; Perner S; Gütgemann I
Histopathology; 2013 Aug; 63(2):157-66. PubMed ID: 23808822
[TBL] [Abstract][Full Text] [Related]
30. Definition of a fluorescence in-situ hybridization score identifies high- and low-level FGFR1 amplification types in squamous cell lung cancer.
Schildhaus HU; Heukamp LC; Merkelbach-Bruse S; Riesner K; Schmitz K; Binot E; Paggen E; Albus K; Schulte W; Ko YD; Schlesinger A; Ansén S; Engel-Riedel W; Brockmann M; Serke M; Gerigk U; Huss S; Göke F; Perner S; Hekmat K; Frank KF; Reiser M; Schnell R; Bos M; Mattonet C; Sos M; Stoelben E; Wolf J; Zander T; Buettner R
Mod Pathol; 2012 Nov; 25(11):1473-80. PubMed ID: 22684217
[TBL] [Abstract][Full Text] [Related]
31. Expression of fibroblast growth factor receptor 1, fibroblast growth factor 2, phosphatidyl inositol 3 phosphate kinase and their clinical and prognostic significance in early and advanced stage of squamous cell carcinoma of the lung.
Usul Afsar C; Sahin B; Gunaldi M; Kılıc Bagir E; Gumurdulu D; Burgut R; Erkisi M; Kara IO; Paydas S; Karaca F; Ercolak V
Int J Clin Exp Pathol; 2015; 8(9):9760-71. PubMed ID: 26617686
[TBL] [Abstract][Full Text] [Related]
32. The clinical pathological characteristics and prognosis of FGFR1 gene amplification in non-small-cell lung cancer: a meta-analysis.
Xie FJ; Lu HY; Zheng QQ; Qin J; Gao Y; Zhang YP; Hu X; Mao WM
Onco Targets Ther; 2016; 9():171-81. PubMed ID: 26793001
[TBL] [Abstract][Full Text] [Related]
33. Characterization of FGFR1 Locus in sqNSCLC Reveals a Broad and Heterogeneous Amplicon.
Rooney C; Geh C; Williams V; Heuckmann JM; Menon R; Schneider P; Al-Kadhimi K; Dymond M; Smith NR; Baker D; French T; Smith PD; Harrington EA; Barrett JC; Kilgour E
PLoS One; 2016; 11(2):e0149628. PubMed ID: 26905262
[TBL] [Abstract][Full Text] [Related]
34. Prognostic and clinicopathological significance of
Wang Y; Wu Y; Li J; Lai Y; Zhou K; Che G
Ann Transl Med; 2019 Nov; 7(22):669. PubMed ID: 31930070
[TBL] [Abstract][Full Text] [Related]
35. Fibroblast growth factor receptor 1 (FGFR1) amplification is a potential therapeutic target in small-cell lung cancer.
Schultheis AM; Bos M; Schmitz K; Wilsberg L; Binot E; Wolf J; Büttner R; Schildhaus HU
Mod Pathol; 2014 Feb; 27(2):214-21. PubMed ID: 23887299
[TBL] [Abstract][Full Text] [Related]
36. Increased SOX2 gene copy number is associated with FGFR1 and PIK3CA gene gain in non-small cell lung cancer and predicts improved survival in early stage disease.
Toschi L; Finocchiaro G; Nguyen TT; Skokan MC; Giordano L; Gianoncelli L; Perrino M; Siracusano L; Di Tommaso L; Infante M; Alloisio M; Roncalli M; Scorsetti M; Jänne PA; Santoro A; Varella-Garcia M
PLoS One; 2014; 9(4):e95303. PubMed ID: 24736592
[TBL] [Abstract][Full Text] [Related]
37. FGFR1/3 tyrosine kinase fusions define a unique molecular subtype of non-small cell lung cancer.
Wang R; Wang L; Li Y; Hu H; Shen L; Shen X; Pan Y; Ye T; Zhang Y; Luo X; Zhang Y; Pan B; Li B; Li H; Zhang J; Pao W; Ji H; Sun Y; Chen H
Clin Cancer Res; 2014 Aug; 20(15):4107-14. PubMed ID: 24850843
[TBL] [Abstract][Full Text] [Related]
38. An mRNA Gene Expression-Based Signature to Identify FGFR1-Amplified Estrogen Receptor-Positive Breast Tumors.
Luo J; Liu S; Leung S; Gru AA; Tao Y; Hoog J; Ho J; Davies SR; Allred DC; Salavaggione AL; Snider J; Mardis ER; Nielsen TO; Ellis MJ
J Mol Diagn; 2017 Jan; 19(1):147-161. PubMed ID: 27993329
[TBL] [Abstract][Full Text] [Related]
39. The role of smoking status on the progression-free survival of non-small cell lung cancer patients harboring activating epidermal growth factor receptor (EGFR) mutations receiving first-line EGFR tyrosine kinase inhibitor versus platinum doublet chemotherapy: a meta-analysis of prospective randomized trials.
Hasegawa Y; Ando M; Maemondo M; Yamamoto S; Isa S; Saka H; Kubo A; Kawaguchi T; Takada M; Rosell R; Kurata T; Ou SH
Oncologist; 2015 Mar; 20(3):307-15. PubMed ID: 25657199
[TBL] [Abstract][Full Text] [Related]
40. The oncogenic role of PKCiota gene amplification and overexpression in Chinese non-small cell lung cancer.
Luo Q; Tang L; Lin H; Huang J; Zhang T; Liu Y; Wang J; Zhan P; Yin X; Su X; Ji Q; Yu D; Xu L
Lung Cancer; 2014 May; 84(2):190-5. PubMed ID: 24636699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]